CDI Bioscience, formerly known as Clonex Development, has patented a technology called RP Shift® that controls cell metabolism to enhance the production of proteins, peptides, and enzymes in mammalian cells. The company's technology can also be applied to bacterial and yeast cellular systems for commercial grade bioproduct manufacturing. CDI Bioscience was founded in 2007 and is based in Madison, United States.